168 related articles for article (PubMed ID: 15313894)
41. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
42. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of T-plastin in Sezary cells.
Su MW; Dorocicz I; Dragowska WH; Ho V; Li G; Voss N; Gascoyne R; Zhou Y
Cancer Res; 2003 Nov; 63(21):7122-7. PubMed ID: 14612505
[TBL] [Abstract][Full Text] [Related]
44. CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas.
Laetsch B; Häffner AC; Döbbeling U; Seifert B; Ludwig E; Burg G; Dummer R
J Invest Dermatol; 2000 Jan; 114(1):107-11. PubMed ID: 10620124
[TBL] [Abstract][Full Text] [Related]
45. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
46. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
47. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
[TBL] [Abstract][Full Text] [Related]
48. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
Klemke CD; Brade J; Weckesser S; Sachse MM; Booken N; Neumaier M; Goerdt S; Nebe TC
Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
[TBL] [Abstract][Full Text] [Related]
49. Induced Sézary syndrome PBMCs poorly express immune response genes up-regulated in stimulated memory T cells.
Chong BF; Dantzer P; Germeroth T; Hafner M; Wilson AJ; Xiao G; Wong HK
J Dermatol Sci; 2010 Oct; 60(1):8-20. PubMed ID: 20801618
[TBL] [Abstract][Full Text] [Related]
50. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
Nagler AR; Samimi S; Schaffer A; Vittorio CC; Kim EJ; Rook AH
J Am Acad Dermatol; 2012 Mar; 66(3):503-8. PubMed ID: 22005074
[TBL] [Abstract][Full Text] [Related]
51. Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.
Möbs M; Gryzik S; Haidar A; Humme D; Beyer M; Vandersee S
Arch Dermatol Res; 2015 Aug; 307(6):479-85. PubMed ID: 25488078
[TBL] [Abstract][Full Text] [Related]
52. Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma.
Whittaker S
J Invest Dermatol; 2016 Sep; 136(9):1753-1754. PubMed ID: 27542296
[TBL] [Abstract][Full Text] [Related]
53. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
[TBL] [Abstract][Full Text] [Related]
54. Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells.
van Kester MS; Out-Luiting JJ; von dem Borne PA; Willemze R; Tensen CP; Vermeer MH
J Invest Dermatol; 2008 Jul; 128(7):1691-5. PubMed ID: 18200050
[TBL] [Abstract][Full Text] [Related]
55. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer.
Martin TA; Goyal A; Watkins G; Jiang WG
Ann Surg Oncol; 2005 Jun; 12(6):488-96. PubMed ID: 15864483
[TBL] [Abstract][Full Text] [Related]
56. [Cutaneous lymphoma of the Sézary and Bouvrain type. Progress in physiopathologic and therapeutic outlook].
Bagot M
Bull Acad Natl Med; 1998; 182(5):927-37; discussion 937-8. PubMed ID: 9735499
[TBL] [Abstract][Full Text] [Related]
57. Aberrant expression of adhesion molecules by Sézary cells: functional consequences under physiologic shear stress conditions.
Hwang ST; Fitzhugh DJ
J Invest Dermatol; 2001 Mar; 116(3):466-70. PubMed ID: 11231324
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.
Kohnken R; Kodigepalli KM; Mishra A; Porcu P; Wu L
Leuk Res; 2017 Jan; 52():58-66. PubMed ID: 27889686
[TBL] [Abstract][Full Text] [Related]
59. Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.
Booken N; Gratchev A; Utikal J; Weiss C; Yu X; Qadoumi M; Schmuth M; Sepp N; Nashan D; Rass K; Tüting T; Assaf C; Dippel E; Stadler R; Klemke CD; Goerdt S
Leukemia; 2008 Feb; 22(2):393-9. PubMed ID: 18033314
[TBL] [Abstract][Full Text] [Related]
60. Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndrome.
Gibson HM; Mishra A; Chan DV; Hake TS; Porcu P; Wong HK
J Invest Dermatol; 2013 Jan; 133(1):249-57. PubMed ID: 22951729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]